Patents by Inventor Jun SHIIHARA

Jun SHIIHARA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for evaluating side-effect onset risk in anticancer drug treatment, including detecting MUC4 gene polymorphism
    Patent number: 9873920
    Abstract: The purpose of the present invention is to provide an evaluation method kit for evaluating the risk of onset of diffuse alveolar damage due to such factors as anticancer drug administration. The purpose of the present invention is also to provide a method for evaluating the risk of onset of side effects in anticancer drug treatment. An evaluation method and evaluation kit for evaluating the risk of onset of diffuse alveolar damage, including detecting gene polymorphism present in the MUC4 gene. A method for evaluating the risk of onset of side effect in anticancer drug treatment, including detecting gene polymorphism present in the MUC4 gene of a patient scheduled for anticancer drug administration.
    Type: Grant
    Filed: February 27, 2014
    Date of Patent: January 23, 2018
    Assignee: SAITAMA MEDICAL UNIVERSITY
    Inventors: Koichi Hagiwara, Hitoshi Miyazawa, Jun Shiihara, Tomoaki Tanaka, Yoshiaki Inoue
  • METHOD FOR EVALUATING SIDE-EFFECT ONSET RISK IN ANTICANCER DRUG TREATMENT, INCLUDING DETECTING MUC4 GENE POLYMORPHISM
    Publication number: 20160002734
    Abstract: The purpose of the present invention is to provide an evaluation method kit for evaluating the risk of onset of diffuse alveolar damage due to such factors as anticancer drug administration. The purpose of the present invention is also to provide a method for evaluating the risk of onset of side effects in anticancer drug treatment. An evaluation method and evaluation kit for evaluating the risk of onset of diffuse alveolar damage, including detecting gene polymorphism present in the MUC4 gene. A method for evaluating the risk of onset of side effect in anticancer drug treatment, including detecting gene polymorphism present in the MUC4 gene of a patient scheduled for anticancer drug administration.
    Type: Application
    Filed: February 27, 2014
    Publication date: January 7, 2016
    Applicant: SAITAMA MEDICAL UNIVERSITY
    Inventors: Koichi HAGIWARA, Hitoshi MIYAZAWA, Jun SHIIHARA, Tomoaki TANAKA, Yoshiaki INOUE